recommended reading

Early Tests Bode Well for Bioterrorism Treatment

Kirill__M/Shutterstock.com

A potential drug for use against Marburg virus has been shown in initial testing to be safe for humans, the Boston Business Journal reported.

Pharmaceutical firm Sarepta Therapeutics announced that when the treatment was given in various dosage amounts over two weeks to 40 volunteers in a Phase 1 study, the drug was discerned to be generally safe, even at the largest dosage level.

Marburg virus is a hemorrhagic fever that can cause death in as many as nine out of 10 infected people. Given its lethality, the virus is a leading biological-terrorism concern.

Sarepta Therapeutics is developing its Marburg drug under a Defense Department contract. Additional work on the medication -- known as AVI-7288 -- depends on Pentagon approval.

Threatwatch Alert

Thousands of cyber attacks occur each day

See the latest threats

JOIN THE DISCUSSION

Close [ x ] More from Nextgov
 
 

Thank you for subscribing to newsletters from Nextgov.com.
We think these reports might interest you:

  • Modernizing IT for Mission Success

    Surveying Federal and Defense Leaders on Priorities and Challenges at the Tactical Edge

    Download
  • Communicating Innovation in Federal Government

    Federal Government spending on ‘obsolete technology’ continues to increase. Supporting the twin pillars of improved digital service delivery for citizens on the one hand, and the increasingly optimized and flexible working practices for federal employees on the other, are neither easy nor inexpensive tasks. This whitepaper explores how federal agencies can leverage the value of existing agency technology assets while offering IT leaders the ability to implement the kind of employee productivity, citizen service improvements and security demanded by federal oversight.

    Download
  • Effective Ransomware Response

    This whitepaper provides an overview and understanding of ransomware and how to successfully combat it.

    Download
  • Forecasting Cloud's Future

    Conversations with Federal, State, and Local Technology Leaders on Cloud-Driven Digital Transformation

    Download
  • IT Transformation Trends: Flash Storage as a Strategic IT Asset

    MIT Technology Review: Flash Storage As a Strategic IT Asset For the first time in decades, IT leaders now consider all-flash storage as a strategic IT asset. IT has become a new operating model that enables self-service with high performance, density and resiliency. It also offers the self-service agility of the public cloud combined with the security, performance, and cost-effectiveness of a private cloud. Download this MIT Technology Review paper to learn more about how all-flash storage is transforming the data center.

    Download

When you download a report, your information may be shared with the underwriters of that document.